We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
-$6.61M
Cap. Flow
-$25.8M
Cap. Flow %
-0.72%
Top 10 Hldgs %
39.47%
Holding
4,012
New
939
Increased
926
Reduced
932
Closed
1,189

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 6.08%
2 Healthcare 5.42%
3 Technology 5.41%
4 Financials 5.37%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
2351
Oramed Pharmaceuticals
ORMP
$171M
$125K ﹤0.01%
+16,077
New +$121K
SVM
2352
Silvercorp Metals
SVM
$2.08B
$125K ﹤0.01%
+38,988
New +$119K
BRW
2353
Saba Capital Income & Opportunities Fund
BRW
$336M
$124K ﹤0.01%
+11,501
New +$124K
EEV icon
2354
ProShares Trust UltraShort MSCI Emerging Markets
EEV
$2.56M
$124K ﹤0.01%
+1,098
New +$131K
SGMO
2355
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$124K ﹤0.01%
+14,061
New +$90.2K
VKTX icon
2356
Viking Therapeutics
VKTX
$3.93B
$124K ﹤0.01%
+114,507
New +$146K
WPG
2357
DELISTED
Washington Prime Group Inc.
WPG
$124K ﹤0.01%
1,645
-223
-12% -$16.8K
ISEE
2358
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$123K ﹤0.01%
48,040
-48,604
-50% -$132K
CXRX
2359
DELISTED
Concordia International Corp. Common Stock
CXRX
$123K ﹤0.01%
78,635
+61,679
+364% +$83.7K
ACGN
2360
DELISTED
Aceragen Inc
ACGN
$122K ﹤0.01%
523
-533
-50% -$139K
MTEM
2361
DELISTED
Molecular Templates, Inc.
MTEM
$122K ﹤0.01%
1,885
+1,822
+2,892% +$143K
LSAK icon
2362
Lesaka Technologies
LSAK
$392M
$121K ﹤0.01%
12,232
-5,107
-29% -$52.1K
ASYS icon
2363
Amtech Systems
ASYS
$257M
$120K ﹤0.01%
14,268
+1,813
+15% +$13.3K
ESTE
2364
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$120K ﹤0.01%
+11,948
New +$149K
MNKD icon
2365
MannKind Corp
MNKD
$1.21B
$119K ﹤0.01%
84,343
-63,609
-43% -$81.8K
PED icon
2366
PEDEVCO
PED
$148M
$119K ﹤0.01%
9,219
+8,328
+935% +$127K
SBS icon
2367
Sabesp
SBS
$19.4B
$119K ﹤0.01%
+64,209
New +$119K
STAA icon
2368
STAAR Surgical
STAA
$1.13B
$118K ﹤0.01%
+10,955
New +$107K
FOCL
2369
EDAP TMS S.A.
FOCL
$227M
$117K ﹤0.01%
+35,601
New +$101K
OFG icon
2370
OFG Bancorp
OFG
$2.24B
$117K ﹤0.01%
+11,659
New +$122K
TPST icon
2371
Tempest Therapeutics
TPST
$13.9M
$117K ﹤0.01%
26
-43
-62% -$182K
UPBD icon
2372
Upbound Group
UPBD
$1.26B
$117K ﹤0.01%
10,017
-91,890
-90% -$1.04M
LBCC
2373
DELISTED
Long Blockchain Corp. Common Stock
LBCC
$117K ﹤0.01%
+21,653
New +$105K
DWAT
2374
DELISTED
Arrow Investments Trust Arrow DWA Tactical ETF
DWAT
$116K ﹤0.01%
10,685
-43,704
-80% -$471K
AGIG
2375
Abundia Global Impact Group
AGIG
$41.8M
$116K ﹤0.01%
1,233
-63
-5% -$3.67K

Similar funds

Virtu KCG Holdings's Q2 2017 Portfolio in Review

As of Q2 2017, Virtu KCG Holdings held 4,012 positions worth $3.6B, down 0.18% from $3.61B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Virtu KCG Holdings's Q2 2017 filing shows 939 new, 926 increased, 932 reduced and 1,189 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 1,021,442 shares worth $28.2M. The largest sale was JPMorgan Chase, an estimated $13.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 6.1% of assets, down from 6.2% a quarter earlier, followed by Healthcare and Technology.

  • Virtu KCG Holdings's largest Q2 2017 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 1,021,442 shares worth $28.2M.
  • Virtu KCG Holdings added most to Alphabet (Google) Class C in Q2 2017, an estimated $13.8M increase.
  • Virtu KCG Holdings's biggest Q2 2017 reduction was JPMorgan Chase, cutting an estimated $13.2M.
  • Virtu KCG Holdings fully exited Viatris in Q2 2017, selling an estimated $7.94M.
  • Virtu KCG Holdings's ten largest holdings make up 39% of its $3.6B portfolio in Q2 2017.
  • Virtu KCG Holdings opened 939 new positions and closed 1,189 in Q2 2017.
  • Virtu KCG Holdings's portfolio value fell 0.18% quarter-over-quarter to $3.6B.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.